The airline accused more than 40 generic drugmakers of engaging in a wide-spanning price-fixing scheme that allegedly cost the company “hundreds of millions” of dollars over the years. More: Southwest Airlines sues dozens of generic drugmakers for alleged price-fixing scheme
read moreSeveral months after the FDA signed off on Bimzelx’s label expansion into hidradenitis suppurativa, UCB is expanding an existing campaign to include the drug’s new indication. More: UCB extends Bimzelx ad campaign in wake of hidradenitis suppurativa approval Source: fierce
read moreNovartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are infected with malaria. The nod is for a new formulation of Coartem, which is also known commercially in come
read moreThe lawsuit brought by the American Academy of Pediatrics, the Infectious Diseases Society of America and others seeks relief on COVID-19 vaccine recommendations for pregnant women and youth, but calls attention to the secretary’s other controversial actions on vaccines. More:
read moreAs summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. More: Novo’s Wegovy retakes top TV spending spot in June, edging out AbbVie, J&J immunology ads Source: fierce
read moreChina’s Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy to become the only U.S.-endorsed oral treatment for those with a rare type of non-small cell lung cancer. More: Dizal to challenge J&J with FDA
read more© 1994 - 2025 B.M. Pharmaceuticals